Dr. Parkkari has over 15 years of experience in drug development across academia and the pharmaceutical and biotechnology industries, with a focus on neuroscience and rare diseases. She has been actively involved in business development, R&D operations, and strategic portfolio management across global pharmaceutical companies, CROs, and academic organizations in Europe and the USA.

Learn more

Justina contributes extensive experience with EU project management, project administration and financial auditing. She has a successful track record of administering several projects on leadership, industrial technologies, information and communication under the European Union “Horizon 2020” funding program.

Learn more

Dr. Jukka Puoliväli earned his Ph.D. in Neuroscience in 2000 from the University of Kuopio, Finland. He continued his post-doctoral research at the Department of Neuroscience and Neurology at the University of Kuopio, before joining the Gladstone Institutes of Neurological Disease at UCSF in San Francisco, where he worked as a post-doctoral researcher from 2002 to 2004.

Learn more

Dr. Demarne has been leading and involved in pharmaceutical operations, fundraising, licensing, and business development for 15 years at international research institutes, biotech start-ups, and pharmaceutical companies in Europe, USA, and China.

Learn more